Psychedelic-assisted psychotherapy: Emerging paradigm. [PDF]
Shane D, Akhtar S, Hapke E.
europepmc +1 more source
Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan. [PDF]
Raffa RB.
europepmc +1 more source
Caution before canonisation: a clinical and implementation science perspective on psychedelics. [PDF]
Paris A +4 more
europepmc +1 more source
Aspirational autonomy and psychedelic-assisted therapy in advanced cancer: ethical lessons from clinical cases. [PDF]
Davis KW +3 more
europepmc +1 more source
Risks from self-medicating with psychedelic drugs. [PDF]
Black JC.
europepmc +1 more source
High ventilation breathwork as a non-pharmacological model for inducing psychedelic-like states: expert evaluations of therapeutic potential and risk. [PDF]
Lueken U +4 more
europepmc +1 more source
Lived experience as systems-relevant evidence in psychedelic public health. [PDF]
Dara P.
europepmc +1 more source
Methodological fragmentation and integration priorities in psychedelic-assisted therapy assessment: a scoping review. [PDF]
Mele ML, Federici S.
europepmc +1 more source
Preparing the body for psilocybin therapy: receptive and generative interoception in cancer patients. [PDF]
Back AL +3 more
europepmc +1 more source

